Roger Stupp

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Physiology

DNA Methylation

Co-author Network

Publications

TOP 3
Ghazaleh Tabatabai; Monika Hegi; Roger Stupp; Michael Weller
Clinical implications of molecular neuropathology and biomarkers for malignant glioma.
Gianfranco A Pesce; Dirk Klingbiel; Karin Ribi; Abderahim Zouhair; Roger von Moos; Marc Schlaeppi; Clemens B Caspar; Natalie Fischer; Sandro Anchisi; Solange Peters; et al.
Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 70/03).
R Stupp; A Tosoni; J E C Bromberg; P Hau; M Campone; J Gijtenbeek; M Frenay; L Breimer; H Wiesinger; A Allgeier; et al.
Sagopilone (ZK-EPO, ZK 219477) for recurrent glioblastoma. A phase II multicenter trial by the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor Group.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Roger Stupp (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Ghazaleh Tabatabai; Monika Hegi; Roger Stupp; Michael Weller
Clinical implications of molecular neuropathology and biomarkers for malignant glioma.
Current neurology and neuroscience reports 2012;12(3):302-7.
2012: Gianfranco A Pesce; Dirk Klingbiel; Karin Ribi; Abderahim Zouhair; Roger von Moos; Marc Schlaeppi; Clemens B Caspar; Natalie Fischer; Sandro Anchisi; Solange Peters; et al.
Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 70/03).
European journal of cancer (Oxford, England : 1990) 2012;48(3):377-84.
2011: R Stupp; A Tosoni; J E C Bromberg; P Hau; M Campone; J Gijtenbeek; M Frenay; L Breimer; H Wiesinger; A Allgeier; et al.
Sagopilone (ZK-EPO, ZK 219477) for recurrent glioblastoma. A phase II multicenter trial by the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(9):2144-9.
2011: Wanyu L Lambiv; Irene Vassallo; Mauro Delorenzi; Tal Shay; Annie-Claire Diserens; Anjan Misra; Burt Feuerstein; Anastasia Murat; Eugenia Migliavacca; Marie-France Hamou; et al.
The Wnt inhibitory factor 1 (WIF1) is targeted in glioblastoma and has a tumor suppressing function potentially by induction of senescence.
Neuro-oncology 2011;13(7):736-47.
2011: Ghazaleh Tabatabai; Jorg-Christian Tonn; Roger Stupp; Michael Weller
The role of integrins in glioma biology and anti-glioma therapies.
Current pharmaceutical design 2011;17(23):2402-10.
2010: Roger Stupp; Michael Weller
2010: neuro-oncology is moving!
Current opinion in neurology 2010;23(6):553-5.
2010: Roger Stupp; Monika Hegi; Michael Weller
Neuro-oncology, a decade of temozolomide and beyond.
Expert review of anticancer therapy 2010;10(11):1675-7.
2010: Ghazaleh Tabatabai; Roger Stupp; Martin J van den Bent; Monika E Hegi; Jörg C Tonn; Wolfgang Wick; Michael Weller
Molecular diagnostics of gliomas: the clinical perspective.
Acta neuropathologica 2010;120(5):585-92.
2010: Giovanni Martinelli; Shu-Fang Hsu Schmitz; Urs Utiger; Thomas Cerny; Urs Hess; Simona Bassi; Emmie Okkinga; Roger Stupp; Rolf Stahel; Marc Heizmann; et al.
Long-term follow-up of patients with follicular lymphoma receiving single-agent rituximab at two different schedules in trial SAKK 35/98.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(29):4480-4.
2010: Michael Weller; Wolfgang Wick; Monika E Hegi; Roger Stupp; Ghazaleh Tabatabai
Should biomarkers be used to design personalized medicine for the treatment of glioblastoma?
Future oncology (London, England) 2010;6(9):1407-14.
2010: Silvia Hofer; Roger Stupp
Targeted therapies on the horizon for malignant glioma.
Targeted oncology 2010;5(3):157-60.
2010: Ghazaleh Tabatabai; Michael Weller; Burt Nabors; Martin Picard; David Reardon; Tom Mikkelsen; Curzio Ruegg; Roger Stupp
Targeting integrins in malignant glioma.
Targeted oncology 2010;5(3):175-81.
2010: Michael Weller; Roger Stupp; Guido Reifenberger; Alba A Brandes; Martin J van den Bent; Wolfgang Wick; Monika E Hegi
MGMT promoter methylation in malignant gliomas: ready for personalized medicine?
Nature reviews. Neurology 2010;6(1):39-51.
2009: Roger Stupp; Michael Mayer; Roger Kann; Walter Weder; Abderahim Zouhair; Daniel C Betticher; Arnaud D Roth; Rolf A Stahel; Sabine Balmer Majno; Solange Peters; et al.
Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial.
The lancet oncology 2009;10(8):785-93.
2009: Michael Weller; David Reardon; Burt Nabors; Roger Stupp
Will integrin inhibitors have proangiogenic effects in the clinic?
Nature medicine 2009;15(7):726; author reply 727.
2009: Carin A Uyl-de Groot; Roger Stupp; Martin van der Bent
Cost-effectiveness of temozolomide for the treatment of newly diagnosed glioblastoma multiforme.
Expert review of pharmacoeconomics & outcomes research 2009;9(3):235-41.
2009: R Stupp; F Roila;
Malignant glioma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20 Suppl 4():126-8.
2009: Andrea Kuemmerle; Laurent A Decosterd; Thierry Buclin; Danielle Liénard; Roger Stupp; Pierre-Guy Chassot; François Mosimann; Ferdy Lejeune
A phase I pharmacokinetic study of hypoxic abdominal stop-flow perfusion with gemcitabine in patients with advanced pancreatic cancer and refractory malignant ascites.
Cancer chemotherapy and pharmacology 2009;63(2):331-41.
2008: Eric Raymond; Alba A Brandes; Christian Dittrich; Pierre Fumoleau; Bruno Coudert; Paul M J Clement; Marc Frenay; Roy Rampling; Roger Stupp; Johan M Kros; et al.
Phase II study of imatinib in patients with recurrent gliomas of various histologies: a European Organisation for Research and Treatment of Cancer Brain Tumor Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(28):4659-65.
2008: Matthias Preusser; Robert Charles Janzer; Jörg Felsberg; Guido Reifenberger; Marie-France Hamou; Annie-Claire Diserens; Roger Stupp; Thierry Gorlia; Christine Marosi; Harald Heinzl; et al.
Anti-O6-methylguanine-methyltransferase (MGMT) immunohistochemistry in glioblastoma multiforme: observer variability and lack of association with patient survival impede its use as clinical biomarker.
Brain pathology (Zurich, Switzerland) 2008;18(4):520-32.
2008: Monika E Hegi; Lili Liu; James G Herman; Roger Stupp; Wolfgang Wick; Michael Weller; Minesh P Mehta; Mark R Gilbert
Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(25):4189-99.
2008: Anastasia Murat; Eugenia Migliavacca; Thierry Gorlia; Wanyu L Lambiv; Tal Shay; Marie-France Hamou; Nicolas de Tribolet; Luca Regli; Wolfgang Wick; Mathilde C M Kouwenhoven; et al.
Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(18):3015-24.
2008: Jerzy Hildebrand; Thierry Gorlia; Johan M Kros; Dénes Afra; Marc Frenay; Antonio Omuro; Roger Stupp; Denis Lacombe; Anouk Allgeier; Martin J van den Bent; et al.
Adjuvant dibromodulcitol and BCNU chemotherapy in anaplastic astrocytoma: results of a randomised European Organisation for Research and Treatment of Cancer phase III study (EORTC study 26882).
European journal of cancer (Oxford, England : 1990) 2008;44(9):1210-6.
2008: R Stupp; F Roila;
Malignant glioma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19 Suppl 2():ii83-5.
2008: Leida M Lamers; Roger Stupp; Martin J van den Bent; Maiwenn J Al; Thierry Gorlia; Jean-Blaise Wasserfallen; Nicole Mittmann; Soo Jin Seung; Ralph Crott; Carin A Uyl-de Groot; et al.
Cost-effectiveness of temozolomide for the treatment of newly diagnosed glioblastoma multiforme: a report from the EORTC 26981/22981 NCI-C CE3 Intergroup Study.
Cancer 2008;112(6):1337-44.
2008: Alba A Brandes; Enrico Franceschi; Alicia Tosoni; Monika E Hegi; Roger Stupp
Epidermal growth factor receptor inhibitors in neuro-oncology: hopes and disappointments.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(4):957-60.
2008: Thierry Gorlia; Martin J van den Bent; Monika E Hegi; René O Mirimanoff; Michael Weller; J Gregory Cairncross; Elizabeth Eisenhauer; Karl Belanger; Alba A Brandes; Anouk Allgeier; et al.
Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3.
The lancet oncology 2008;9(1):29-38.
2007: Roger Stupp; Monika E Hegi; Mark R Gilbert; Arnab Chakravarti
Chemoradiotherapy in malignant glioma: standard of care and future directions.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(26):4127-36.
2007: Roger Stupp; Alessia Pica; René O Mirimanoff; Olivier Michielin
[A practical guide for the management of gliomas].
Bulletin du cancer 2007;94(9):817-22.
2007: Christophe Paus; Anastasia Murat; Roger Stupp; Luca Regli; Monika Hegi
[Role of MGMT and clinical applications in brain tumours].
Bulletin du cancer 2007;94(9):769-73.
2007: M Mauer; R Stupp; M J B Taphoorn; C Coens; D Osoba; C Marosi; R Wong; O de Witte; J G Cairncross; F Efficace; et al.
The prognostic value of health-related quality-of-life data in predicting survival in glioblastoma cancer patients: results from an international randomised phase III EORTC Brain Tumour and Radiation Oncology Groups, and NCIC Clinical Trials Group study.
British journal of cancer 2007;97(3):302-7.
2007: Arnaud D Roth; Nicola Fazio; Roger Stupp; Stephen Falk; Jürg Bernhard; Piercarlo Saletti; Dieter Köberle; Markus M Borner; Kaspar Rufibach; Rudolf Maibach; et al.
Docetaxel, cisplatin, and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: a randomized phase II trial of the Swiss Group for Clinical Cancer Research.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(22):3217-23.
2007: W Weder; R A Stahel; J Bernhard; S Bodis; P Vogt; P Ballabeni; D Lardinois; D Betticher; R Schmid; R Stupp; et al.
Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(7):1196-202.
2007: Roger Stupp; Monika E Hegi
Methylguanine methyltransferase testing in glioblastoma: when and how?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(12):1459-60.
2007: Roger Stupp; Monika E Hegi
Targeting brain-tumor stem cells.
Nature biotechnology 2007;25(2):193-4.
2007: Peter Hau; Roger Stupp; Monika E Hegi
MGMT methylation status: the advent of stratified therapy in glioblastoma?
Disease markers 2007;23(1-2):97-104.
2007: Roger Stupp; Monika E Hegi
Neuro-oncology: oligodendroglioma and molecular markers.
Lancet neurology 2007;6(1):10-2.
2006: Marc Voeffray; André Pannatier; Roger Stupp; Nadia Fucina; Serge Leyvraz; Jean-Blaise Wasserfallen
Effect of computerisation on the quality and safety of chemotherapy prescription.
Quality & safety in health care 2006;15(6):418-21.
2006: Thorsten Krueger; Andrea Kuemmerle; Snezana Andrejevic-Blant; Hua Yan; Youmin Pan; Jean-Pierre Ballini; Walter Klepetko; Laurent Arthur Decosterd; Roger Stupp; Hans-Beat Ris
Antegrade versus retrograde isolated lung perfusion: doxorubicin uptake and distribution in a sarcoma model.
The Annals of thoracic surgery 2006;82(6):2024-30.
2006: V Voelter; A Zouhair; H Vuilleumier; M Matter; H Bouzourene; S Leyvraz; J Bauer; P Coucke; R Stupp
CPT-11 and concomitant hyperfractionated accelerated radiotherapy induce efficient local control in rectal cancer patients: results from a phase II.
British journal of cancer 2006;95(6):710-6.
2006: M E Hegi; A Murat; W L Lambiv; R Stupp
Brain tumors: molecular biology and targeted therapies.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17 Suppl 10():x191-7.
2006: Nicole Mutter; Roger Stupp
Temozolomide: a milestone in neuro-oncology and beyond?
Expert review of anticancer therapy 2006;6(8):1187-204.
2006: Thorsten Krueger; Andrea Kuemmerle; Marek Kosinski; Alban Denys; Lennard Magnusson; Roger Stupp; Angelika Bischof Delaloye; Walter Klepetko; Laurent Decosterd; Hans-Beat Ris; et al.
Cytostatic lung perfusion results in heterogeneous spatial regional blood flow and drug distribution: evaluation of different cytostatic lung perfusion techniques in a porcine model.
The Journal of thoracic and cardiovascular surgery 2006;132(2):304-11.
2006: Vincent Ganière; Grégoire Christen; Frank Bally; Louis Guillou; Alessia Pica; Sandrine de Ribaupierre; Roger Stupp
Listeria brain abscess, Pneumocystis pneumonia and Kaposi's sarcoma after temozolomide.
Nature clinical practice. Oncology 2006;3(6):339-43; quiz following 343.
2006: René-Olivier Mirimanoff; Thierry Gorlia; Warren Mason; Martin J Van den Bent; Rolf-Dieter Kortmann; Barbara Fisher; Michele Reni; Alba A Brandes; Jüergen Curschmann; Salvador Villa; et al.
Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(16):2563-9.
2006: D C Betticher; S-F Hsu Schmitz; M Tötsch; E Hansen; C Joss; C von Briel; R A Schmid; M Pless; J Habicht; A D Roth; et al.
Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study.
British journal of cancer 2006;94(8):1099-106.
2006: S Peters; V Voelter; L Zografos; S Pampallona; R Popescu; M Gillet; W Bosshard; G Fiorentini; M Lotem; R Weitzen; et al.
Intra-arterial hepatic fotemustine for the treatment of liver metastases from uveal melanoma: experience in 101 patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(4):578-83.
2006: Martin J van den Bent; Monika E Hegi; Roger Stupp
Recent developments in the use of chemotherapy in brain tumours.
European journal of cancer (Oxford, England : 1990) 2006;42(5):582-8.
2006: Antoine Leimgruber; Sandrine Ostermann; Eun Jo Yeon; Evelyn Buff; Philippe P Maeder; Roger Stupp; Reto A Meuli
Perfusion and diffusion MRI of glioblastoma progression in a four-year prospective temozolomide clinical trial.
International journal of radiation oncology, biology, physics 2006;64(3):869-75.
2006: Roger Stupp; Monika E Hegi; Martin J van den Bent; Warren P Mason; Michael Weller; René O Mirimanoff; J Gregory Cairncross; ;
Changing paradigms--an update on the multidisciplinary management of malignant glioma.
The oncologist 2006;11(2):165-80.
2006: Khalil Zaman; Robert Driscoll; Diane Hahn; Patricia Werffeli; Simon L Goodman; Jean Bauer; Serge Leyvraz; Ferdy Lejeune; Roger Stupp; Curzio Rüegg
Monitoring multiple angiogenesis-related molecules in the blood of cancer patients shows a correlation between VEGF-A and MMP-9 levels before treatment and divergent changes after surgical vs. conservative therapy.
International journal of cancer. Journal international du cancer 2006;118(3):755-64.
2006: Amir R Dehdashti; Monika E Hegi; Luca Regli; Alessia Pica; Roger Stupp
New trends in the medical management of glioblastoma multiforme: the role of temozolomide chemotherapy.
Neurosurgical focus 2006;20(4):E6.
2006: Monika E Hegi; Roger Stupp
Correlative studies in neuro-oncology trials: should they influence treatment?
Current oncology reports 2006;8(1):54-7.
2005: Martin J B Taphoorn; Roger Stupp; Corneel Coens; David Osoba; Rolf Kortmann; Martin J van den Bent; Warren Mason; René O Mirimanoff; Brigitta G Baumert; Elizabeth Eisenhauer; et al.
Health-related quality of life in patients with glioblastoma: a randomised controlled trial.
The lancet oncology 2005;6(12):937-44.
2005: Edgardo Pezzetta; Roger Stupp; Abderrahim Zouhair; Louis Guillou; Patrick Taffé; Christian von Briel; Thorsten Krueger; Hans-Beat Ris
Comparison of neoadjuvant cisplatin-based chemotherapy versus radiochemotherapy followed by resection for stage III (N2) NSCLC.
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2005;27(6):1092-8.
2005: Khalil Zaman; Nicholas Ketterer; Diane Vulliémoz; Roger Stupp; Serge Leyvraz
[New systemic therapies in oncology].
Revue médicale suisse 2005;1(20):1361-2, 1364-5.
2005: Isabel Filges; Khalil Zaman; Olivier Michielin; Diane Vulliémoz; Lucien Perey; Roger Stupp
[Present chemoprevention and future vision].
Revue médicale suisse 2005;1(20):1343-6, 1349.
2005: Roger Stupp; Martin J van den Bent; Monika E Hegi
Optimal role of temozolomide in the treatment of malignant gliomas.
Current neurology and neuroscience reports 2005;5(3):198-206.
2005: Y Seium; R Stupp; T Ruhstaller; P Gervaz; G Mentha; M Philippe; A Allal; C Trembleau; J Bauer; R Morant; et al.
Oxaliplatin combined with irinotecan and 5-fluorouracil/leucovorin (OCFL) in metastatic colorectal cancer: a phase I-II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(5):762-6.
2005: Jean-Blaise Wasserfallen; Sandrine Ostermann; Serge Leyvraz; Roger Stupp
Cost of temozolomide therapy and global care for recurrent malignant gliomas followed until death.
Neuro-oncology 2005;7(2):189-95.
2005: Monika E Hegi; Annie-Claire Diserens; Thierry Gorlia; Marie-France Hamou; Nicolas de Tribolet; Michael Weller; Johan M Kros; Johannes A Hainfellner; Warren Mason; Luigi Mariani; et al.
MGMT gene silencing and benefit from temozolomide in glioblastoma.
The New England journal of medicine 2005;352(10):997-1003.
2005: Roger Stupp; Warren P Mason; Martin J van den Bent; Michael Weller; Barbara Fisher; Martin J B Taphoorn; Karl Belanger; Alba A Brandes; Christine Marosi; Ulrich Bogdahn; et al.
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.
The New England journal of medicine 2005;352(10):987-96.
2004: Jean-Blaise Wasserfallen; Sandrine Ostermann; Alessia Pica; René-Olivier Mirimanoff; Serge Leyvraz; Jean-Guy Villemure; Roger Stupp
Can we afford to add chemotherapy to radiotherapy for glioblastoma multiforme? Cost-identification analysis of concomitant and adjuvant treatment with temozolomide until patient death.
Cancer 2004;101(9):2098-105.
2004: Roger Stupp; Christian Monnerat; Andrew T Turrisi; Michael C Perry; Serge Leyvraz
Small cell lung cancer: state of the art and future perspectives.
Lung cancer (Amsterdam, Netherlands) 2004;45(1):105-17.
2004: Michele Ghielmini; Shu-Fang Hsu Schmitz; Sergio B Cogliatti; Gabriella Pichert; Jörg Hummerjohann; Ursula Waltzer; Martin F Fey; Daniel C Betticher; Giovanni Martinelli; Fedro Peccatori; et al.
Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly x 4 schedule.
Blood 2004;103(12):4416-23.
2004: Sandrine Ostermann; Chantal Csajka; Thierry Buclin; Serge Leyvraz; Ferdy Lejeune; Laurent A Decosterd; Roger Stupp
Plasma and cerebrospinal fluid population pharmacokinetics of temozolomide in malignant glioma patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(11):3728-36.
2004: O Michielin; E Udry; D Périard; O Matzinger; J A Lobrinus; R Stupp
Irinotecan-induced interstitial pneumonia.
The lancet oncology 2004;5(5):322-4.
2004: A D Roth; R Maibach; N Fazio; C Sessa; R Stupp; R Morant; R Herrmann; M M Borner; A Goldhirsch; F de Braud
5-Fluorouracil as protracted continuous intravenous infusion can be added to full-dose docetaxel (Taxotere)-cisplatin in advanced gastric carcinoma: a phase I-II trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(5):759-64.
2004: Monika E Hegi; Annie-Claire Diserens; Sophie Godard; Pierre-Yves Dietrich; Luca Regli; Sandrine Ostermann; Philippe Otten; Guy Van Melle; Nicolas de Tribolet; Roger Stupp
Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(6):1871-4.
2004: Abderrahim Zouhair; David Azria; Philippe Pasche; Roger Stupp; Julia Chevalier; Michael Betz; René O Mirimanoff; Mahmut Ozsahin
Accelerated postoperative radiotherapy with weekly concomitant boost in patients with locally advanced head and neck cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2004;70(2):183-8.
2003: René O Mirimanoff; Roger Stupp
Radiotherapy in low-grade gliomas: Cons.
Seminars in oncology 2003;30(6 Suppl 19):34-8.
2003: Roger Stupp; Robert C Janzer; Monika E Hegi; Jean-Guy Villemure; René O Mirimanoff
Prognostic factors for low-grade gliomas.
Seminars in oncology 2003;30(6 Suppl 19):23-8.
2003: Curzio Rüegg; Jean-Yves Meuwly; Robert Driscoll; Patricia Werffeli; Khalil Zaman; Roger Stupp
The quest for surrogate markers of angiogenesis: a paradigm for translational research in tumor angiogenesis and anti-angiogenesis trials.
Current molecular medicine 2003;3(8):673-91.
2003: M J van den Bent; W Grisold; D Frappaz; R Stupp; J P Desir; T Lesimple; C Dittrich; M J A de Jonge; A Brandes; M Frenay; et al.
European Organization for Research and Treatment of Cancer (EORTC) open label phase II study on glufosfamide administered as a 60-minute infusion every 3 weeks in recurrent glioblastoma multiforme.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(12):1732-4.
2003: Sophie Godard; Gad Getz; Mauro Delorenzi; Pierre Farmer; Hiroyuki Kobayashi; Isabelle Desbaillets; Michimasa Nozaki; Annie-Claire Diserens; Marie-France Hamou; Pierre-Yves Dietrich; et al.
Classification of human astrocytic gliomas on the basis of gene expression: a correlated group of genes with angiogenic activity emerges as a strong predictor of subtypes.
Cancer research 2003;63(20):6613-25.
2003: Verena Voelter; Roger Stupp; Maurice Matter; Michel Gillet; Hanifa Bouzourene; Serge Leyvraz; Philippe Coucke
Preoperative hyperfractionated accelerated radiotherapy (HART) and concomitant CPT-11 in locally advanced rectal carcinoma: a phase I study.
International journal of radiation oncology, biology, physics 2003;56(5):1288-94.
2003: M J van den Bent; M J B Taphoorn; A A Brandes; J Menten; R Stupp; M Frenay; O Chinot; J M Kros; C C D van der Rijt; Ch J Vecht; et al.
Phase II study of first-line chemotherapy with temozolomide in recurrent oligodendroglial tumors: the European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(13):2525-8.
2003: Daniel C Betticher; Shu-Fang Hsu Schmitz; Martin Tötsch; Eva Hansen; Christine Joss; Christian von Briel; Ralph A Schmid; Miklos Pless; James Habicht; Arnaud D Roth; et al.
Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(9):1752-9.
2003: Curzio Rüegg; Jelena Zaric; Roger Stupp
Non steroidal anti-inflammatory drugs and COX-2 inhibitors as anti-cancer therapeutics: hypes, hopes and reality.
Annals of medicine 2003;35(7):476-87.
2002: E Raymond; M Campone; R Stupp; J Menten; P Chollet; T Lesimple; R Fety-Deporte; D Lacombe; X Paoletti; P Fumoleau; et al.
Multicentre phase II and pharmacokinetic study of RFS2000 (9-nitro-camptothecin) administered orally 5 days a week in patients with glioblastoma multiforme.
European journal of cancer (Oxford, England : 1990) 2002;38(10):1348-50.
2002: Markus M Borner; Daniel Dietrich; Roger Stupp; Rudolf Morant; Hanspeter Honegger; Martin Wernli; Richard Herrmann; Bernhard C Pestalozzi; Piercarlo Saletti; Silvia Hanselmann; et al.
Phase II study of capecitabine and oxaliplatin in first- and second-line treatment of advanced or metastatic colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(7):1759-66.
2002: Roger Stupp; Pierre-Yves Dietrich; Sandrine Ostermann Kraljevic; Alessia Pica; Ivan Maillard; Phillipe Maeder; Reto Meuli; Robert Janzer; Gianpaolo Pizzolato; Raymond Miralbell; et al.
Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(5):1375-82.
2001: R Stupp; M Gander; S Leyvraz; E Newlands
Current and future developments in the use of temozolomide for the treatment of brain tumours.
The lancet oncology 2001;2(9):552-60.
2001: G Pichert; S F Schmitz; U Hess; T Cerny; S B Cogliatti; D Betticher; R Stupp; D Schmitter; R A Stahel; M Ghielmini
Weekly x 4 induction therapy with the anti-CD20 antibody rituximab: effect on circulating t(14;18)(+) follicular lymphoma cells.
Clinical lymphoma 2001;1(4):293-7.
2001: R Stupp; A Bodmer; B Duvoisin; J Bauer; L Perey; M Bakr; N Ketterer; S Leyvraz
Is cisplatin required for the treatment of non-small-cell lung cancer? Experience and preliminary results of a phase I/II trial with topotecan and vinorelbine.
Oncology 2001;61 Suppl 1():35-41.
2000: K Mattson; L Bosquee; G Dabouis; A Le Groumellec; J L Pujol; S Marien; R Stupp; J Y Douillard; B Brägas; J Berille; et al.
Phase II study of docetaxel in the treatment of patients with advanced non-small cell lung cancer in routine daily practice.
Lung cancer (Amsterdam, Netherlands) 2000;29(3):205-16.
2000: K Mattson; J Vansteenkiste; R Stupp; M Bargetzi; A Saarinen; A Jekunen; G Fillet; M Teixeira; U Gatzemeier; R Olivares; et al.
Phase II study of docetaxel alternating with cisplatin in chemotherapy-naïve patients with advanced non-small cell lung cancer.
Anti-cancer drugs 2000;11(1):7-13.
2000: M Ghielmini; S F Schmitz; K Bürki; G Pichert; D C Betticher; R Stupp; M Wernli; A Lohri; D Schmitter; F Bertoni; et al.
The effect of Rituximab on patients with follicular and mantle-cell lymphoma. Swiss Group for Clinical Cancer Research (SAKK).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11 Suppl 1():123-6.